Kingsview Wealth Management LLC Grows Position in Cigna Group $CI

Kingsview Wealth Management LLC raised its stake in shares of Cigna Group (NYSE:CIFree Report) by 37.8% during the third quarter, HoldingsChannel reports. The firm owned 48,994 shares of the health services provider’s stock after purchasing an additional 13,442 shares during the quarter. Kingsview Wealth Management LLC’s holdings in Cigna Group were worth $14,122,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in CI. Harbor Capital Advisors Inc. grew its holdings in shares of Cigna Group by 119.5% during the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after buying an additional 49 shares during the last quarter. Collier Financial purchased a new position in Cigna Group in the 3rd quarter worth $34,000. NewSquare Capital LLC lifted its position in Cigna Group by 38.8% during the 2nd quarter. NewSquare Capital LLC now owns 143 shares of the health services provider’s stock worth $47,000 after acquiring an additional 40 shares during the period. Traub Capital Management LLC purchased a new stake in Cigna Group during the 2nd quarter valued at about $48,000. Finally, Access Investment Management LLC acquired a new position in shares of Cigna Group in the second quarter valued at about $49,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Cigna Group Trading Up 0.3%

Cigna Group stock opened at $289.73 on Monday. The firm has a market cap of $77.39 billion, a PE ratio of 13.06, a P/E/G ratio of 1.01 and a beta of 0.27. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00. The stock’s 50 day simple moving average is $279.98 and its two-hundred day simple moving average is $284.54. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.74.

Cigna Group (NYSE:CIGet Free Report) last posted its earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, beating the consensus estimate of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The firm had revenue of $72.50 billion during the quarter, compared to analyst estimates of $69.53 billion. During the same period in the previous year, the firm earned $6.64 EPS. The business’s quarterly revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Analysts anticipate that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be given a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date is Thursday, March 5th. Cigna Group’s payout ratio is currently 28.13%.

Analyst Ratings Changes

A number of equities research analysts recently commented on CI shares. Barclays decreased their target price on Cigna Group from $305.00 to $303.00 and set an “overweight” rating for the company in a report on Friday, February 6th. Truist Financial raised their price target on shares of Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a research report on Tuesday, February 17th. Mizuho set a $325.00 price objective on shares of Cigna Group in a research note on Friday, January 9th. UBS Group reiterated a “buy” rating and issued a $375.00 price objective on shares of Cigna Group in a research note on Monday, February 9th. Finally, JPMorgan Chase & Co. reduced their target price on shares of Cigna Group from $428.00 to $375.00 and set an “overweight” rating for the company in a report on Tuesday, November 4th. One research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, Cigna Group presently has an average rating of “Moderate Buy” and a consensus target price of $330.63.

View Our Latest Stock Analysis on Cigna Group

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Read More

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.